Low dose ramipril is not optimal in diabetes
FONTE
BMJ Publishing Group Ltd.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=351823Documentos Relacionados
- Colchicine in acute gout: Optimal dose of colchicine is still elusive
- Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study)
- Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study)
- Biodisponibilidade comparativa de duas formulações de ramipril em voluntarios sadios apos administração de dose unica
- Low dose desensitisation does not reduce the toxicity of sulphasalazine in rheumatoid arthritis.